Track topics on Twitter Track topics that are important to you
AmorChem is pleased to announce the addition of Fondaction to the limited partners of the AmorChem II Fund L.P. The fund initially closed on September 19, 2017, having raised capi...
With its second fund recently closed, AmorChem is proud to announce the composition of its scientific advisory committee. AmorChem selected these highly qualified individuals beca...
Inversago Pharma Inc. raised $7mm through its Series A financing co-led by Genesys Capital and AmorChem, which were joined by JDRF T1D Fund, Accel-Rx, Anges Québec Capital, Tarnagulla Ventures, and a...
SemaThera Inc announces today the closing of a $2MUS co-investment from Senju Pharmaceutical Co., Ltd. and AmorChem L.P. for the development of its lead candidate, ST-102, in prep...
Senju Pharma of Osaka in-licensed China and Japan rights to a potential treatment for diabetic macular edema (DME) from Montreal's SemaThera. Senju also paired up with AmorChem L.P. to make a $2 milli...
Proceeds will support the development of new generations of cannabinoid-1 (CB1) receptor inverse agonists for the treatment of several metabolic diseases including Prader-Willi Sy...
AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating p...
We have published hundreds of AMORCHEM L.P. news stories on BioPortfolio along with dozens of AMORCHEM L.P. Clinical Trials and PubMed Articles about AMORCHEM L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AMORCHEM L.P. Companies in our database. You can also find out about relevant AMORCHEM L.P. Drugs and Medications on this site too.
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...